Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Abagovomab does not prolong survival of patients with ovarian cancer in MIMOSA trial

June 7, 2011

Morphotek begins phase II MORAb-004 study in melanoma

June 6, 2011

Adaptimmune begins phase I/II trial of T-cell therapy in multiple myeloma

June 2, 2011

R1-1084 and R1-770 well tolerated by patients with metastatic renal cell carcinoma

June 1, 2011

Ongoing phase I/II trial suggests safety of CDCA1-A24-56 vaccine in patients with CRPC

May 26, 2011

Daiichi Sankyo and AstraZeneca enter copromotion agreement for denosumab in Japan

May 24, 2011

Northwest Biotherapeutics and Fraunhofer enter partnership for DCVax-L

May 20, 2011

CITN selects recombinant IL-7 CYT-107 for clinical testing at network institutions

May 18, 2011

AMP-224 boosts BCG-induced immune responses against bladder cancer

May 18, 2011

Promising phase II data reported on CT-011 in diffuse large B-cell lymphoma

May 17, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...